Dr. Dmochowski on tibial nerve stimulation as an earlier line of therapy for OAB

In this video, Roger R. Dmochowski, MD, MMHC, highlights the FDA approval of the BlueWind Revi System, specifically touching on how the device is being recognized as a potential earlier line of therapy for patients with overactive bladder (OAB). Dmochowski is the chief medical officer at BlueWind Medical as well as a professor of urology, gynecology, and surgery and Vanderbilt University Medical Center in Nashville, Tennesee.